Cyclerion Therapeutics, Inc. (KRSA) vs Nanobiotix S.A. - Sponsored ADR (NBTX)
Cyclerion Therapeutics, Inc. and Nanobiotix S.A. - Sponsored ADR are both Biotechnology companies. Cyclerion Therapeutics, Inc. and Nanobiotix S.A. - Sponsored ADR are of similar size ($1.7B and $1.7B). Across the 12 metrics below, Nanobiotix S.A. - Sponsored ADR leads on 8 and Cyclerion Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | KRSA | NBTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (98.22%) | 0.00% | (57.72%) |
| Return on assets | (82.29%) | 0.00% | (49.22%) |
| Return on invested capital | (115.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack